selonabant
selonabant: developed by 1 company · 1 clinical trial tracked.
selonabant evidence translation
What we can confirm
1 tracked trial
What it means
Source-backed records connect selonabant to ANEB; that link alone does not prove the drug works.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
How could selonabant → ANEB affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | Phase 2 |
Clinical Trials (1)
A Phase 1, Randomized, Double-Blind, Placebo Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous Selonabant in Healthy Adult Subjects Aged 18 to 30 Years
Primary endpoint: Number of Participants with Adverse Events
InterventionalRandomizedquadruple40 enrolledStarted 2025-09Completion 2026-051 site · United StatesAnebulo Pharmaceuticals
Frequently asked questions
Who is developing selonabant?
selonabant is being developed by Anebulo Pharmaceuticals, Inc..
How many clinical trials involve selonabant?
BioSniper tracks 1 clinical trial involving selonabant.